Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Centenara Labs is an integrated biotechnology platform company that invests in people and ideas to develop therapies.
Noetik is an AI-native biotechnology company that applies machine learning to large-scale human multimodal spatial omics datasets.
TapestryHealth provides telemedicine services including primary care, emergency care, and various health screenings.
Leo Cancer Care develops radiation therapy technologies that support cancer treatment in an upright patient position.
Ratio Therapeutics is a clinical-phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.
Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.
Cambrian is a distributed development company building therapeutics to lengthen health span.
AdvanCell develops targeted alpha radiopharmaceutical therapies for cancer and supports their development and manufacturing.
Bayesian Health is an adaptive AI platform that offers health systems through clinical AI.
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.
Flourish Labs combines humans, AI & tech to provide employee coaching and AI-powered peer mental health support.
Axena Health develops commercial-stage medical devices for women's pelvic health.
Visby Medical is a diagnostics company that develops polymerase chain reaction diagnostic tests for the detection of infectious diseases.
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Thea is an AI-powered skincare and dermatology app that gives personalized skincare advice, product recommendations.
Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.
Cage Pharma is a pre-clinical biopharmaceutical company that develops new drugs targeting the metabolism of tumors.
9amHealth offers a simplified approach to whole body health, focusing on weight loss, diabetes management, and heart health.
ArriVent develops pharmaceutical products to cure presently untreatable cancer.
Catalio Capital Management has invested in 132 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Catalio Capital Management's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Biopharma. The firm invests across 23 different industry categories.
Among tracked funding rounds, Flourish received $500.0M in a Series A round. Catalio Capital Management's total known invested capital is $9.5B.
Catalio Capital Management's average investment size is $75.8M across its portfolio of 132 companies.
Recent Catalio Capital Management portfolio additions include EGenesis, Fractyl Health, Volastra Therapeutics, Centenara Labs, Noetik. These companies were founded in 2020 or later.